A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery.
BACKGROUND:Visceral leishmaniasis is a neglected parasitic disease with no vaccine available and its pharmacological treatment is reduced to a limited number of unsafe drugs. The scarce readiness of new antileishmanial drugs is even more alarming when relapses appear or the occurrence of hard-to-tre...
Main Authors: | Raquel Álvarez-Velilla, Maria Del Camino Gutiérrez-Corbo, Carmen Punzón, Maria Yolanda Pérez-Pertejo, Rafael Balaña-Fouce, Manuel Fresno, Rosa María Reguera |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-02-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC6392311?pdf=render |
Similar Items
-
Infrared fluorescent imaging as a potent tool for in vitro, ex vivo and in vivo models of visceral leishmaniasis.
by: Estefanía Calvo-Álvarez, et al.
Published: (2015-03-01) -
Antiparasitic effect of synthetic aromathecins on Leishmania infantum
by: Rosa M. Reguera, et al.
Published: (2019-11-01) -
Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum
by: Camino Gutiérrez-Corbo, et al.
Published: (2019-12-01) -
Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of <i>Leishmania donovani</i> Visceral Leishmaniasis
by: Estela Melcon-Fernandez, et al.
Published: (2023-01-01) -
Axenic interspecies and intraclonal hybrid formation in Leishmania: Successful crossings between visceral and cutaneous strains
by: Camino Gutiérrez-Corbo, et al.
Published: (2022-02-01)